Saja Asakrah, MD
-
RolePathology
-
Research Program
-
Practicing Since
Biography
Saja Asakrah, MD, is an assistant professor in the Department of Pathology and Laboratory Medicine at Emory University School of Medicine. Dr. Asakrah is board certified in anatomic and clinical pathology and hematopathology.
Titles & Roles
-
Assistant Professor, Department of Pathology and Laboratory MedicineEmory University School of Medicine
Education & Training
Education
- Fellowship, Pathology-Hematology, 2017Beth Israel Deaconess Hospital
- Residency, Anatomic Pathology & Clinical Pathology, 2016St John Hospital & Medical Center
- Professional Education, PhD, 2012Tulane School of Medicine
- Residency, 2008Baghdad University College of Medicine
- Residency, 2007Baghdad University College of Medicine
- Internship, 2003Baghdad University College of Medicine
- Internship, 2001Baghdad Medical City
- Medical Education, 2001Baghdad University College of Medicine
Board Certifications
- HematopathologyAmerican Board of Pathology, 2017Anatomic PathologyAmerican Board of Pathology, 2016Clinical PathologyAmerican Board of Pathology, 2016
Research
Publications
Title/Journal Authors Publication Date Leukemia research reports
S Asakrah, KK Deeb, N Papadantonakis, G Deeb 01/01/2025 Ulcerative Jejunitis in Celiac Disease: A 30-Year US Experience.
The American journal of gastroenterology
Y Chornenkyy, M Peric, DM Flores, Y Ono, SA Shinagare, K Dannheim, S Shannahan, S Rakowsky, S Asakrah, M Vyas, J Arnason, D Leffler, C Kelly, R Mukherjee, A Therrien 10/30/2024 EBV-Positive Nodal T- and NK-Cell Lymphoma Mimicking Anaplastic Large Cell Lymphoma: A Case Report.
Hematology reports
B Abro, P Allen, S Asakrah, K Bradley, L Zhang 05/23/2024 Laboratory medicine
A Khanna, BR Drumheller, G Deeb, EW Tolbert, S Asakrah 11/02/2023 Blood
M Attieh, S Asakrah 04/20/2023 B-ALL with synchronous MYC and BCL-2 rearrangement.
Blood
M Attieh, S Asakrah 04/13/2023 American journal of clinical pathology
S Asakrah, R Davis, P Bhargava 11/08/2021 The need for new test verification and regulatory support for innovative diagnostics.
Nature biotechnology
JD Roback, EA Tyburski, D Alter, S Asakrah, A Chahroudi, A Esper, S Farmer, J Figueroa, J K Frediani, M D Gonzalez, D S Gottfried, J Guarner, N A Gupta, S S Heilman, C E Hill, R Jerris, R R Kempker, J Ingersoll, JM Levy, M Mavigner, C S Moreno, C R Morris, E J Nehl, A S Neish, D Peker, N Saakadze, PA Rebolledo, C A Rostad, N Schoof, A Suessmith, J Sullivan, YFW Wang, A Wood, MB Vos, O Brand, GS Martin, WA Lam 09/01/2021 Ratings & Reviews
Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.